Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen ; volume:13 ; number:1 ; day:31 ; month:1 ; year:2011 ; pages:1-12 ; date:2.2011
Breast cancer research ; 13, Heft 1 (31.1.2011), 1-12, 2.2011
- Urheber
-
Brennan, Donal J.
- Beteiligte Personen und Organisationen
-
Laursen, Henriette
O'Connor, Darran P.
Borgquist, Signe
Uhlén, Mathias
Gallagher, William M.
Pontén, Fredrik
Millikan, Robert C.
Rydén, Lisa
Jirström, Karin
SpringerLink (Online service)
- DOI
-
10.1186/bcr2820
- URN
-
urn:nbn:de:1111-2016032411476
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.09.0171, 09:32 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Brennan, Donal J.
- Laursen, Henriette
- O'Connor, Darran P.
- Borgquist, Signe
- Uhlén, Mathias
- Gallagher, William M.
- Pontén, Fredrik
- Millikan, Robert C.
- Rydén, Lisa
- Jirström, Karin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
HMG-CoA reductase inhibitors
Selection of HMG-coenzyme A reductase inhibitors using multiattribute scoring tool
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
Transcription of the three HMG-CoA reductase genes of Mucor circinelloides
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer
HMG
HMG
HMG
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
HMG-CoA reductase inhibitors
Selection of HMG-coenzyme A reductase inhibitors using multiattribute scoring tool
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
Transcription of the three HMG-CoA reductase genes of Mucor circinelloides
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer
HMG
HMG
HMG
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
HMG-CoA reductase inhibitors
Selection of HMG-coenzyme A reductase inhibitors using multiattribute scoring tool
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
Transcription of the three HMG-CoA reductase genes of Mucor circinelloides
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer
HMG
HMG